Mathers, John C., Elliott, Faye, Lindblom, Annika, Morrison, Patrick J., Rashbass, Jem, Ramesar, Raj S., Seppälä, Toni T., Thomas, Huw J. W., Sheth, Harsh J., Pylvänäinen, Kirsi, Reed, Lynn, Borthwick, Gillian M., Macrae, Finlay, Bishop, D. Timothy, Burn, J, Boussioutas, A, Brewer, C, Cook, J, Eccles, D, Ellis, A, Hodgson, SV, Lubinski, J, Maher, ER, Mecklin, Jukka-Pekka, Porteous, MEM, Sampson, J, Scott, Rodney J., Side, L, Bisgaard, ML, Chu, C, Fidalgo, P, Fidalgo, P, Gallinger, S, Homfray, T, Möslein, Gabriela, Hutter, P, Leite, J, MacKay, J, Marks, CG, Miles, A, Murday, V, Oliani, C, Olschwang, S, Segura, PP, Pichert, G, McRonald, Fiona E., Sappino, AP, Tempesta, A, Vasen, HFA, Walpole, I, Langman, C, Shand, B, Bacon, A, Bertario, Lucio, Evans, D. Gareth, Gerdes, Anne-Marie, Ho, Judy W. C.. American Association for Cancer Research; 2022. Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up.

Burn, John, Bishop, Timothy, Bertario, Lucio, Jarvinen, Heikki J., Lindblom, Annika, Evans, D. Gareth, Lubinski, Jan, Morrison, Patrick J., Ho, Judy W. C., Vasen, Hans F. A., Side, Lucy, Thomas, Huw J. W., Mecklin, Jukka-Pekka, Scott, Rodney J., Dunlop, Malcolm, Barker, Gail, Elliott, Faye, Jass, Jeremy R., Fodde, Ricardo, Lynch, Henry T., Mathers, John C., Macrae, Finlay, Moslein, Gabriela, Olschwang, Sylviane, Bisgaard, Marie-Luise, Ramesar, Raj, Eccles, Diana, Maher, Eamonn R.. Massachusetts Medical Society; 2008. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

Movahedi, Mohammad, Bishop, D. Timothy, Bisgaard, Marie-Luise, Dunlop, Malcolm G., Ho, Judy W. C., Hodgson, Shirley V., Lindblom, Annika, Lubinski, Jan, Morrison, Patrick J., Murday, Victoria, Ramesar, Raj S., Side, Lucy, Macrae, Finlay, Scott, Rodney J., Thomas, Huw J. W., Vasen, Hans F., Burn, John, Mathers, John C., Mecklin, Jukka-Pekka, Moeslein, Gabriela, Olschwang, Sylviane, Eccles, Diana, Evans, D. Gareth, Maher, Eamonn R., Bertario, Lucio. American Society of Clinical Oncology; 2015. Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: a prospective investigation in the CAPP2 study.

Burn, John, Sheth, Harsh, Gerdes, Anne-Marie, Ho, Judy W. C., Lindblom, Annika, Morrison, Patrick J., Rashbass, Jem, Ramesar, Raj, Seppälä, Toni, Thomas, Huw J. W., Pylvänäinen, Kirsi, Borthwick, Gillian M., Elliott, Faye, Mathers, John C., Bishop, DT, Boussioutas, A, Brewer, C, Cook, J, Eccles, D, Ellis, A, Hodgson, SV, Lubinski, J, Maher, ER, Reed, Lynn, Porteous, ME, Sampson, J, Scott, RJ, Side, L, Macrae, Finlay, Mecklin, Jukka-Pekka, Möslein, Gabriela, McRonald, Fiona E., Bertario, Lucio, Evans, D. Gareth. Lancet; 2020. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.

Burn, John, Gerdes, Anne-Marie, Bisgaard, Marie Louise, Dunlop, Malcolm G., Ho, Judy W. C., Hodgson, Shirley V., Lindblom, Annika, Lubinski, Jan, Morrison, Patrick J., Murday, Victoria, Ramesar, Raj, Side, Lucy, Macrae, Finlay, Scott, Rodney J., Thomas, Huw J. W., Vasen, Hans F., Barker, Gail, Crawford, Gillian, Elliott, Faye, Movahedi, Mohammad, Pylvanainen, Kirsi, Wijnen, Juul T., Fodde, Riccardo, Mecklin, Jukka-Pekka, Lynch, Henry T., Mathers, John C., Bishop, D. Timothy, Moeslein, Gabriela, Olschwang, Sylviane, Eccles, Diane, Evans, D. Gareth, Maher, Eamonn R., Bertario, Lucio. Lancet Publishing Group; 2011. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.